Fig. 3: Probability of OS by ATLG-dose. | Bone Marrow Transplantation

Fig. 3: Probability of OS by ATLG-dose.

From: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Fig. 3

Probability of overall survival (OS) by ATLG-dose - unadjusted and from Cox regression model adjusted for center, patient age, donor age, CMV status of patient, type of disease, disease status, time from primary diagnosis of current disease to transplantation, HLA-mismatch.

Back to article page